Company Filing History:
Years Active: 2014-2025
Title: The Innovative Contributions of Guillaume Maitro
Introduction
Guillaume Maitro is a prominent inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release PTH compounds. With a total of 13 patents to his name, Maitro's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Among his latest patents is the invention titled "Incremental dose finding in controlled-release PTH compounds." This invention relates to pharmaceutical compositions that comprise a controlled-release PTH compound or a pharmaceutically acceptable salt, hydrate, or solvate thereof. The method aims to treat, control, delay, or prevent conditions that can be managed with PTH, allowing for dose adjustments in increments of no more than 25% in response to hypocalcemia or hypercalcemia. Another notable patent is focused on a method of treating or controlling hypoparathyroidism in human patients. This involves administering a pharmaceutical composition that includes a controlled-release PTH compound, which is designed to be injected subcutaneously no more frequently than once every 24 hours.
Career Highlights
Guillaume Maitro has worked with notable companies in the pharmaceutical industry, including Ascendis Pharma Bone Diseases A/S and Ascendis Pharma A/S. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Maitro has collaborated with esteemed colleagues such as Kennett Sprogøe and Thomas Wegge. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Guillaume Maitro's innovative work in the field of pharmaceuticals, particularly with controlled-release PTH compounds, showcases his dedication to improving medical treatments. His contributions through numerous patents highlight the importance of innovation in addressing health challenges.